Erasca Inc. Common Stock vs Lockheed Martin Corporation — how do they compare? Erasca Inc. Common Stock trades at $15.37 (market cap $5.40B), while Lockheed Martin Corporation trades at $506.53 (market cap $117.22B). The key difference: Lockheed Martin Corporation is far larger — about 21.7× Erasca Inc. Common Stock's market cap, and Lockheed Martin Corporation pays a 2.72% dividend while Erasca Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Erasca Inc. Common Stock for 0 Days and Lockheed Martin Corporation for 86 Days on average.
| ERAS | LMT | |
|---|---|---|
Market Cap | $5.40B | $117.22B |
Volume | 9,533,185 | 1,101,121 |
Sector | Health | Industrials |
52-Week High | $22.47 | $676.70 |
52-Week Low | $2.20 | $439.19 |
Typical Hold Time | 0 Days | 86 Days |
Enterprise Value | $5.18B | $133.96B |
Dividend Yield | — | 2.72% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Lockheed Martin (LMT) trades at $499.22, down 2.14% on the day, amid a bearish technical signal and recent earnings volatility. The company reported revenue growth to $75.05B in 2025, but net income margin declined to 6.68%. Analyst consensus remains bullish with a $635.33 price target, supported by strong defense spending trends and a 23-year dividend growth streak. Recent news highlights AI integration and F-35 program developments, though fixed-price contract risks persist.
LMT offers value with a P/E of 18.41 and robust cash flow, but faces execution risks from contract missteps and debt levels near 36% of assets. Upside hinges on defense budget continuity and operational efficiency, while margin pressure and competitive threats from peers like Boeing pose challenges. The stock's current discount to analyst targets presents a potential entry point for long-term investors, balanced by near-term technical weakness.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Erasca is a biotechnology company developing precision medicines for cancer. Its programs target genetic drivers of tumor growth.
Read more on ERAS →Lockheed Martin is the largest defense contractor globally and has dominated the Western market for high-end fighter aircraft since the F-35 program was awarded in 2001. Lockheed's largest segment is aeronautics, which is dominated by the massive F-35 program. Lockheed's remaining segments are rotary and mission systems, which is mainly the Sikorsky helicopter business.
Read more on LMT →